ATE162401T1 - Antivitale zusammensetzungen - Google Patents

Antivitale zusammensetzungen

Info

Publication number
ATE162401T1
ATE162401T1 AT93915909T AT93915909T ATE162401T1 AT E162401 T1 ATE162401 T1 AT E162401T1 AT 93915909 T AT93915909 T AT 93915909T AT 93915909 T AT93915909 T AT 93915909T AT E162401 T1 ATE162401 T1 AT E162401T1
Authority
AT
Austria
Prior art keywords
pct
sec
combinations
pharmaceutically acceptable
antivitial
Prior art date
Application number
AT93915909T
Other languages
English (en)
Inventor
Janet Mary Cameron
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE162401T1 publication Critical patent/ATE162401T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT93915909T 1992-07-16 1993-07-13 Antivitale zusammensetzungen ATE162401T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929215178A GB9215178D0 (en) 1992-07-16 1992-07-16 Antiviral combinations

Publications (1)

Publication Number Publication Date
ATE162401T1 true ATE162401T1 (de) 1998-02-15

Family

ID=10718844

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93915909T ATE162401T1 (de) 1992-07-16 1993-07-13 Antivitale zusammensetzungen

Country Status (12)

Country Link
US (1) US5612333A (de)
EP (1) EP0650363B1 (de)
JP (1) JPH07508998A (de)
AT (1) ATE162401T1 (de)
AU (1) AU672022B2 (de)
CA (1) CA2140238C (de)
DE (1) DE69316621T2 (de)
DK (1) DK0650363T3 (de)
ES (1) ES2111755T3 (de)
GB (1) GB9215178D0 (de)
GR (1) GR3026141T3 (de)
WO (1) WO1994002155A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9503850D0 (en) * 1995-02-25 1995-04-19 Glaxo Group Ltd Medicaments
PL192361B1 (pl) * 1997-08-25 2006-10-31 Boehringer Ingelheim Pharma Kompozycja farmaceutyczna hemihydratu newirapiny i sposób wytwarzania wodnej zawiesiny hemihydratu newirapiny
US7713739B1 (en) 2000-11-17 2010-05-11 Novartis Vaccines And Diagnostics, Inc. Microparticle-based transfection and activation of dendritic cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660917B1 (fr) * 1990-04-11 1992-11-20 Perrier Rene Pince de prehension et machine de traitement d'objets, notamment de bouteilles, ainsi equipee.
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
WO1992017159A2 (en) * 1991-04-03 1992-10-15 Richardson-Vicks Inc. Stabilized emulsion compositions for imparting an artificial tan to human skin
WO1992020344A1 (en) * 1991-05-16 1992-11-26 Glaxo Group Limited Antiviral combinations containing nucleoside analogs

Also Published As

Publication number Publication date
JPH07508998A (ja) 1995-10-05
EP0650363B1 (de) 1998-01-21
GR3026141T3 (en) 1998-05-29
AU4568993A (en) 1994-02-14
US5612333A (en) 1997-03-18
DE69316621D1 (de) 1998-02-26
CA2140238C (en) 2004-04-20
GB9215178D0 (en) 1992-08-26
ES2111755T3 (es) 1998-03-16
CA2140238A1 (en) 1994-02-03
DE69316621T2 (de) 1998-05-07
DK0650363T3 (da) 1998-09-21
EP0650363A1 (de) 1995-05-03
WO1994002155A1 (en) 1994-02-03
AU672022B2 (en) 1996-09-19

Similar Documents

Publication Publication Date Title
TW366347B (en) Antiviral pharmaceutical compositions comprising 1,3-oxathiolane nucleoside analogues
MY109796A (en) 1,3-oxathiolane nucleoside analogues.
ES2179040T3 (es) Utilizacion de 5-fluoro-2'-desoxi-3'-tiacitidina para el tratamiento de la hepatitis b.
YU49698A (sh) Smeše koje sadrže tetrahidrolipstatin
MA26458A1 (fr) Nouveaux derives cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2757522B1 (fr) Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
BR0214806A (pt) Composições farmacêuticos de 5,7,14-triazatetraciclo-{10.3.1.02,11.0,4,9]-hexadeca-2(1 1),3,5,7,9-penteno
IL101145A0 (en) Pharmaceutical compositions containing synergistic combinations of nucleoside derivatives
GEP20022647B (en) Synergistic Combinations
FR2762843B1 (fr) Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
RU94013464A (ru) Нуклеозидные аналоги 1,3-оксатиолана, способ получения, фармацевтическая композиция, способ лечения вирусной инфекции
MXPA03005464A (es) Agentes antivirales.
DE69713151D1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
MX9200361A (es) Nuevo uso del antagonista de adenosina.
YU74292A (sh) Jedinjenja za inhibiciju hiv i srodnih virusa
ATE213940T1 (de) Parenteral anzuwendende arzneizubereitung enthaltend amiodaron
MY127808A (en) Use of dideoxy nucleoside analogues in the treatment of viral infections
AR012868A1 (es) COMPOSICIoN FARMACÉUTICA QUE COMPRENDE UN PÉPTIDO AGONISTA DE LHRH, UN ANTAGONISTA DE LHRH O UN PÉPTIDO DE GRF Y NICOTINAMIDA.
DE69316621D1 (de) Antivitale zusammensetzungen
SE0001916D0 (sv) Novel formulation
BR9808823A (pt) (-)e-2- (3,4-diclorocinamil) -1-ciclopropilmetil-piperidina e seu uso antidiarréico
YU34793A (sh) Derivati proteina c
MY113560A (en) Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification